Tarsus Pharmaceuticals (TARS) Leases (2020 - 2025)
Historic Leases for Tarsus Pharmaceuticals (TARS) over the last 6 years, with Q3 2025 value amounting to $10.2 million.
- Tarsus Pharmaceuticals' Leases rose 46786.9% to $10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.2 million, marking a year-over-year increase of 46786.9%. This contributed to the annual value of $552000.0 for FY2024, which is 7063.83% down from last year.
- As of Q3 2025, Tarsus Pharmaceuticals' Leases stood at $10.2 million, which was up 46786.9% from $229000.0 recorded in Q2 2025.
- In the past 5 years, Tarsus Pharmaceuticals' Leases ranged from a high of $10.2 million in Q3 2025 and a low of $229000.0 during Q2 2025
- Over the past 5 years, Tarsus Pharmaceuticals' median Leases value was $926000.0 (recorded in 2022), while the average stood at $1.6 million.
- Over the last 5 years, Tarsus Pharmaceuticals' Leases had its largest YoY gain of 46786.9% in 2025, and its largest YoY loss of 8836.97% in 2025.
- Tarsus Pharmaceuticals' Leases (Quarter) stood at $1.1 million in 2021, then crashed by 46.46% to $575000.0 in 2022, then skyrocketed by 226.96% to $1.9 million in 2023, then plummeted by 70.64% to $552000.0 in 2024, then soared by 1753.8% to $10.2 million in 2025.
- Its last three reported values are $10.2 million in Q3 2025, $229000.0 for Q2 2025, and $393000.0 during Q1 2025.